HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Anabasine

HCID 205586
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
494-52-0
Standard SMILES
c1cncc([C@@H]2CCCCN2)c1
InChIKey
MTXSIJUGVMTTMU-JTQLQIEISA-N
Molecular formula
C10H14N2
Average molar mass
162.23 g/mol
Monoisotopic mass
162.11569846

Overview

(S)-anabasine is the (S)-enantiomer of anabasine.

Names & identifiers

Preferred name
Anabasine
IUPAC
3-[(2S)-piperidin-2-yl]pyridine
English name
(S)-Anabasine
Molecular formula
C10H14N2
Molecular weight
162.23

Names & synonyms

494-52-0Anabasine(-)-Anabasine(S)-anabasineNeonicotineNeonikotinAnabasinS-(-)-Anabasine3-[(2S)-piperidin-2-yl]pyridineAnabazinL-3-(2'-Piperidyl)pyridinePiperidine, 2-(3-pyridyl)-
Show more names
3-[(2S)-piperidin-2-yl]pyridine (anabasine)ANOBASINENeonikotiL-ANABASINE(-)-anabasin
(-)-2-(3'-Pyridyl)piperidinePyridine, 3-(2-piperidinyl)-, (S)-Pyridine, 3-(2S)-2-piperidinyl-Pyridine, 3-(2-piperidyl)-DTXSID90416073-(2-Piperidinyl)pyridine2-(3'-Pyridyl) piperidineLMS11II2LO

Database identifiers

CAS
494-52-0
PubChem CID
205586
DTXSID
DTXSID9041607
ChEMBL
CHEMBL1526229
ChEBI
CHEBI:74
UNII
LMS11II2LO
EC Number
207-791-3
Nikkaji
J3.284K

Properties

Computed structural properties

XLogP
1
Topological polar surface area
24.9 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
2
Rotatable bonds
1
Heavy atoms
12
Formal charge
0
Complexity
136

Experimental & physicochemical properties

Chemical ClassesBiological Agents -> Plant Toxins
SpringerMaterials PropertiesDensity
LogP · 2 items

log Kow = 0.97 @ pH 7.2

0.97

Density1.0455 @ 20 °C/4 °C
Color/FormColorless liquid, darkens on exposure to air
Solubility · 3 items

Soluble in most organic solvents

Soluble in alcohol and ether

Miscible in water @ 25 °C

Boiling Point270-272 °C
DecompositionWhen heated to decomposition it emits toxic fumes of /nitrogen oxides/.
Melting PointFP: 9 °C
Vapor Pressure0.00301 [mmHg]
Refractive IndexIndex of refraction: 1.5430 @ 20 °C/D; specific optical rotation: -83.1 deg @ 20 °C/D
Physical DescriptionColorless liquid; Darkens on exposure to air; [Hawley] Yellow liquid; [MSDSonline]

Physicochemical properties

Melting point
9 °C · 9°C
Boiling point
270 · 270-272°C
alpha
20 · D20 -83.1°
Density
1 · 1,0455 g/cm3
refractive index
1.543 · 1.5430
Flash point
93 °C · 93°C
storage temp.
2 · 2-8°C
solubility
100 mg/mL · DMSO : 100 mg/mL (616.41 mM)
pka
8.98 · 8.98±0.10(Predicted)
form
Liquid
color
Colorless to light yellow
Merck
14 · 14,619
BRN
82637 · 82637
Major Application
pharmaceutical (small molecule)
InChI
1S/C10H14N2/c1-2-7-12-10(5-1)9-4-3-6-11-8-9/h3-4,6,8,10,12H,1-2,5,7H2/t10-/m0/s1
InChIKey
MTXSIJUGVMTTMU-JTQLQIEISA-N
SMILES
N1[C@@H](CCCC1)c2cnccc2
CAS DataBase Reference
494 · 494-52-0(CAS DataBase Reference)
FDA UNII
11 II2LO · LMS11II2LO
NIST Chemistry Reference
3 · Pyridine, 3-(2-piperidinyl)-, (S)-(494-52-0)
EPA Substance Registry System
Anabasine (494-52-0)
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Symbol(GHS)
9 · GHS09,GHS06
Signal word
Danger
Hazard statements
310 · H310-H411-H300
Precautionary statements
262 · P262-P264-P270-P280-P302+P350-P310-P322-P361-P363-P405-P501-P264-P270-P301+P310-P321-P330-P405-P501
Hazard Codes
T
Risk Statements
27 · 27/28-51/53-23/24/25
Safety Statements
28 · 28-36/37-45-61-36/37/39-28A
RIDADR
3140 · 3140
WGK Germany
3 · WGK 3
RTECS
4375000 · BV4375000
HazardClass
6.1 · 6.1
PackingGroup
I
HS Code
29333990 · 29333990
Storage Class
10 · 10 - Combustible liquids
Hazard Classifications
2 Repr · Eye Irrit. 2Repr. 2Skin Irrit. 2
Hazardous Substances Data
494 · 494-52-0(Hazardous Substances Data)
Toxicity
50 mg/kg · LDLo orl-dog: 50 mg/kg JPETAB 48,95,33

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 6 items

This chemical does not meet GHS hazard criteria for 11.1% (1 of 9) of reports.

Danger

H300 (55.6%): Fatal if swallowed [Danger Acute toxicity, oral]

P203, P262, P264, P264+P265, P270, P273, P280, P301+P316, P302+P352, P305+P351+P338, P316, P318, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 9 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Warning

Hazard information

Hazards SummaryIn high-dose animal studies, causes ataxia and convulsions; Oral LD50 (dog) = 50 mg/kg; [RTECS] Acute toxicity similar to that of nicotine and more severe in guinea pigs and rabbits; [HSDB] See Nicotine.
Hazard Classes and Categories · 2 items

Acute Tox. 1 (55.6%)

Flammable liquids - Category 4

Safety & protection

Disposal Methods · 1 item

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Toxicology

Treatment · 1 item

If the compound has been ingested, rapid gastric lavage should be performed using 5% sodium bicarbonate. For skin contact, the skin should be washed with soap and water. If the compound has entered the eyes, they should be washed with large quantities of isotonic saline or water. In serious cases, atropine and/or pralidoxime should be administered. Anti-cholinergic drugs work to counteract the effects of excess acetylcholine and reactivate AChE. Atropine can be used as an antidote in conjunction with pralidoxime or other pyridinium oximes (such as trimedoxime or obidoxime), though the use of '-oximes' has been found to be of no benefit, or possibly harmful, in at least two meta-analyses. Atropine is a muscarinic antagonist, and thus blocks the action of acetylcholine peripherally.

InteractionsANABASINE ENHANCED SEDATIVE ACTION OF RESERPINE, APOMORPHINE, & 5-HYDROXYTRYPTOPHAN IN FROGS & INHIBITED SEROTONIN UPTAKE BY HUMAN THROMBOCYTES.
Health Effects · 1 item

Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, increased bronchial secretions, increased salivation, lacrimation, sweating, peristalsis, and urination can occur. Certain reproductive effects in fertility, growth, and development for males and females have been linked specifically to organophosphate pesticide exposure. Most of the research on reproductive effects has been conducted on farmers working with pesticides and insecticdes in rural areas. In females menstrual cycle disturbances, longer pregnancies, spontaneous abortions, stillbirths, and some developmental effects in offspring have been linked to organophosphate pesticide exposure. Prenatal exposure has been linked to impaired fetal growth and development. Neurotoxic effects have also been linked to poisoning with OP pesticides causing four neurotoxic effects in humans: cholinergic syndrome, intermediate syndrome, organophosphate-induced delayed polyneuropathy (OPIDP), and chronic organophosphate-induced neuropsychiatric disorder (COPIND). These syndromes result after acute and chronic exposure to OP pesticides.

Environmental Fate · 3 items

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 80(SRC), determined from a log Kow of 0.97(2) and a regression-derived equation(3), suggests that anabasine is expected to have high mobility in soil(SRC). However, anabasine has a pKa of 11.0(4), which indicates that this compound will exist in the protonated form at environmental pH values, and cations adsorb more strongly to soils than neutral molecules. Therefore, the mobility of anabasine is expected to be much lower than predicted(SRC). Volatilization of anabasine from moist soil surfaces will not an important fate process(SRC) as it will exist in the protonated form in the environment and the protonated form will not volatilize(SRC). Anabasine is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 6.6X10-3 mm Hg(SRC), determined from a fragment constant method(5).

AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 80(SRC), determined from a log Kow of 0.97(2) and a regression-derived equation(3), indicates that anabasine is not expected to adsorb to suspended solids and sediment(SRC). A pKa of 11.0(4) indicates anabasine will exist entirely in the ionized form at pH values of 5 to 9 and therefore volatilization from water surfaces is not expected to be an important fate process. According to a classification scheme(5), an estimated BCF of 3(SRC), from its log Kow(2) and a regression-derived equation(6), suggests the potential for bioconcentration in aquatic organisms is low(SRC).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), anabasine, which has an estimated vapor pressure of 6.6X10-3 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), is expected to exist solely as a vapor in the ambient atmosphere. Vapor-phase anabasine is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 4 hours(SRC), calculated from its rate constant of 1.0X10-10 cu cm/molecule-sec at 25 °C(SRC) determined using a structure estimation method(3).

Adverse EffectsNeurotoxin - Other CNS neurotoxin
Exposure RoutesOral (ingestion) (L1817) ; dermal (L1817)
Toxicity Summary · 1 item

Anabasine is a cholinesterase or acetylcholinesterase (AChE) inhibitor. A cholinesterase inhibitor (or 'anticholinesterase') suppresses the action of acetylcholinesterase. Because of its essential function, chemicals that interfere with the action of acetylcholinesterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses, followed by muscle spasms and ultimately death. Nerve gases and many substances used in insecticides have been shown to act by binding a serine in the active site of acetylcholine esterase, inhibiting the enzyme completely. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop. Among the most common acetylcholinesterase inhibitors are phosphorus-based compounds, which are designed to bind to the active site of the enzyme. The structural requirements are a phosphorus atom bearing two lipophilic groups, a leaving group (such as a halide or thiocyanate), and a terminal oxygen.

Plant ConcentrationsAnabasine is the principal alkaloid of Anabasis aphylla, present at 1-2% in the shoots, and is also found to about 1% in Nicotiana glauca(1).
Signs and Symptoms · 1 item

Anabasine produces symptoms similar to nicotine poisoning, such as nausea, abdominal pain, vomiting, diarrhea, diaphoresis, flushing, dizziness, disturbed hearing and vision, confusion, weakness, palpitations, altered respiration and hypotension. (L327)

Soil Adsorption/Mobility · 1 item

The Koc of anabasine is estimated as 80(SRC), using a measured log Kow of 0.97(1) and a regression-derived equation(2). According to a classification scheme(3), this estimated Koc value suggests that anabasine is expected to have high mobility in soil. However, the pKa of anabasine is 11.00(4), which indicates that this compound will exist in the protonated form under environmental pH values and cations adsorb more strongly to soil surfaces than neutral molecules (SRC).

Natural Pollution Sources · 2 items

IN ANABASIS APHYLLA L, CHENOPODIACEAE...IN NICOTIANA GLAUCA GRAHAM, SOLANACEAE...

Anabasine is the principal alkaloid of Anabasis aphylla, present at 1-2% in the shoots, and is also found to about 1% in Nicotiana glauca(1).

Human Toxicity Excerpts · 5 items

SYMPTOMATOLOGY: 1. BURNING SENSATION IN MOUTH & THROAT, SALIVATION, NAUSEA, ABDOMINAL PAIN, VOMITING, DIARRHEA. GI REACTIONS ARE LESS SEVERE BUT DO OCCUR AFTER CUTANEOUS & RESP EXPOSURES. /NICOTINE/

SYMPTOMATOLOGY: 2. SYSTEMIC EFFECTS INCL HEADACHE, SWEATING, DIZZINESS, AUDITORY & VISUAL DISTURBANCES, CONFUSION, WEAKNESS, & INCOORDINATION. 3. AT FIRST RESP...DEEP & RAPID, BLOOD PRESSURE...HIGH...PULSE...SLOW. INTENSE VAGAL STIMULATION MAY CAUSE TRANSIENT CARDIAC STANDSTILL OR PAROXYSMAL ATRIAL FIBRILLATION. PUPILS ARE GENERALLY CONSTRICTED. /NICOTINE/

SYMPTOMATOLOGY: 4. CENTRAL NERVOUS EXCITATION...EVIDENCED BY TREMORS & SOMETIMES BY CLONIC-TONIC CONVULSIONS. 5. AS DEPRESSION DEVELOPS, PUPILS DILATE, BLOOD PRESSURE FALLS AND PULSE BECOMES RAPID & OFTEN IRREGULAR. FAINTNESS, PROSTRATION, CYANOSIS & DYSPNEA PROGRESS TO COLLAPSE. 6. DEATH FROM PARALYSIS OF RESPIRATORY MUSCLES. /NICOTINE/

A 29 YR OLD MAN USED THERAPEUTIC CLYSMA OF TAR FOR RECTAL PROLAPSE. HE EXPERIENCED SHARP GENERAL WEAKNESS, VERTIGO & NAUSEA. WHEN EXAM, HE WAS IN EXTREMELY CRITICAL CONDITION. CARDIOVASCULAR SIGNS WERE DISTURBED & THERE WAS ACROCYANOSIS & LOWERED BODY TEMP; PT WAS STILL CONSCIOUS. 35 MIN AFTER 1ST AID RESP BECAME SEVERLY DEPRESSED & HE BECAME UNCONSCIOUS. THERE WAS MARKED CYANOSIS. URINATION WAS FREQUENT & PAINLESS. ANALYSIS OF URINE & STOMACH CONTENTS DEMONSTRATED ALKALOID ANABASINE. NO SEQUELAE APPEARED ON LATER FOLLOW UP.

Acute & subacute toxicity: increased salivation, vertigo, confusion, disturbed vision & hearing, photophobia, cold extremities, nausea, vomiting, diarrhea, syncope, colonic spasms.

Safety data

wgk
WGK 3
rtecs
BV4375000
ridadr
3140
hs_code
29333990
Toxicity
LDLo orl-dog: 50 mg/kg JPETAB 48,95,33
risk_code
27/28-51/53-23/24/25
Signal word
Danger
Symbol(GHS)
GHS09,GHS06
hazard_code
T
safety_code
28-36/37-45-61-36/37/39-28A
hazard_class
6.1
Storage Class
10 - Combustible liquids
packing_group
I
Hazard statements
H310-H411-H300
Hazard Classifications
Eye Irrit. 2Repr. 2Skin Irrit. 2
Precautionary statements
P262-P264-P270-P280-P302+P350-P310-P322-P361-P363-P405-P501-P264-P270-P301+P310-P321-P330-P405-P501
Hazardous Substances Data
494-52-0(Hazardous Substances Data)

Chemistry & industry

Pharmacology

Mechanism of Action · 2 items

...ANABASINE AFFECT/S/ THE GANGLION OF THE INSECT CENTRAL NERVOUS SYSTEM, FACILITATING TRANS-SYNAPTIC CONDUCTION AT LOW CONCENTRATIONS AND BLOCKING CONDUCTION AT HIGHER LEVELS.

ANABASINE EXERTED NEUROMUSCULAR BLOCKING EFFECT ON ISOLATED RAT PHRENIC NERVE-DIAPHRAGM WHICH COULD BE PARTIALLY ANTAGONIZED BY NEOSTIGMINE. IT IS A DEPOLARIZING MUSCLE RELAXANT WITH SOME CHARACTERISTICS OF COMPETITIVE MUSCLE RELAXANTS.

Metabolism/Metabolites · 2 items

IN VITRO METABOLISM OF (-)-METHYLANABASINE BY RAT, RABBIT & GUINEA PIG GAVE (-)-ANABASINE WHICH WAS METABOLIZED TO 1'-N-HYDROXYANABASINE & ANABASINE 1'DELTA-NITRONE. METABOLIC PRODUCTS OF FORTIFIED LUNG MICROSOMAL FRACTIONS WERE SIMILAR.

Paraoxonase (PON1) is a key enzyme in the metabolism of organophosphates. PON1 can inactivate some organophosphates through hydrolysis. PON1 hydrolyzes the active metabolites in several organophosphates insecticides as well as, nerve agents such as soman, sarin, and VX. The presence of PON1 polymorphisms causes there to be different enzyme levels and catalytic efficiency of this esterase, which in turn suggests that different individuals may be more susceptible to the toxic effect of OP exposure.

MeSH Pharmacological ClassificationPesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics.
Absorption, Distribution and ExcretionAnabasine is readily absorbed from the skin and from mucous membranes.

Uses & manufacturing

Uses · 6 items

Used as an insecticide; No longer used in the US or the UK; The principal alkaloid of the plant Anabasis aphylla; [HSDB]

No longer used as a pesticide in the US or UK; [HSDB]

Farming (Pesticides) [Category: Industry]

For Anabasine (USEPA/OPP Pesticide Code: 006001) there are 0 labels match. /SRP: Not registered for current use in the U.S., but approved pesticide uses may change periodically and so federal, state and local authorities must be consulted for currently approved uses./

Anabasine is no longer used as an insecticide in the United States or the United Kingdom.

Anabasine is a plant toxin found in the Tree Tobacco plant (Nicotiana glauca). It is similar to nicotine and has been used as an insecticide. Anabasine is also present in small amounts in tobacco smoke. (L1265)

Methods of Manufacturing · 2 items

Extracted on a large scale in Russia. Industrial extraction processes: Sadykov, Timbekov; J Appl Chem USSR 29: 148 (1956).

Derivation: (1) Extraction from Anabasis aphylla and Nicotiana glauca, (2) synthetic

General Manufacturing Information · 3 items

Neo-nicotine is a name given to a synthetic anabasine (the DL isomer) produced and tested in the US by the Department of Agriculture.

ANABASINE WAS FIRST DESCRIBED BY AP OREKHOV IN 1929 IN THE PLANT ANABASIS APHYLLA WHICH GROWS IN LARGE QUANTITIES IN CENTRAL ASIA. FOR USE IN AGRICULTURE A 40% AQUEOUS SOLUTION OF THE SULFATES OF THE TOTAL ALKALOIDS OF ANABASIS IS PUT OUT. THE TOTAL ALKALOIDS CONTAIN 70% OF ANABASINE & 30% OTHER ALKALOIDS. IT IS PRACTICALLY EQUAL TO NICOTINE IN INSECTICIDAL ACTIVITY.

Anabasine...is the principal alkaloid of Anabasis aphylla, present at 1-2% in the shoots, and is also found to about 1% in Nicotiana glauca.

Applications

UsesAnabasine occurs in the tobacco speciesNicotiana glauca, Anabasis aphylla L.,Chenopodiaceae, and Solanaceae. It is usedas an insecticide and as a metal anticorrosiveagent.

Uses(S)-ANABASINE is used as a kind of Nicotinic receptor agonist.

Upstream & downstream products

Upstream raw materials

(R)-3-(PIPERIDIN-2-YL)PYRIDINE5-OXO-5-(3-PYRIDYL)VALERIC ACIDN-tert-Butoxycarbonylanabasine3-Pyridinecarboxaldehyde

Downstream products

(R,S)-N-NITROSOANABASINE(S)-3-(Piperidin-2-yl)pyrdine, chlorohydrate (1:1)

Suppliers95 total

阿诺西(上海)生物技术有限公司400-1107768 15058188853 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
成都超九八生物科技有限公司13348960310 13348960310 · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
上海炎泽化工有限公司15345144255 19975051755 · [email protected]
杭州品高化工有限公司0571-87658025 · [email protected]
上海腾准生物科技有限公司19821570922 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
成都普睿法药物研发有限公司82633860 18982077548 · [email protected]
北京索莱宝科技有限公司010-50973130 17801761073 · [email protected]
武汉易泰科技有限公司上海分公司18930552037 · [email protected]
阿法埃莎(中国)化学有限公司400-6106006 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
梯希爱(上海)化工贸易有限公司021-61109150 · [email protected]
海济医药科技(苏州)有限公司18012778619 · [email protected]
成都普思生物科技股份有限公司028-85370565-229 18080489829 · [email protected]
銳迪國際科技有限公司18024082417 · [email protected]
山东沃德森生物科技有限公司0531-88723173 18596073690 · [email protected]
佛山宝诺生物科技有限公司0757-85921206 18520245316 · [email protected]
湖北扬信医药科技有限公司0714-3999001 19171453112 · [email protected]
ChemeGen 中国18818260767 · [email protected]
玛雅试剂+86 (573) 82222445 (0)18006601000 452520369 · [email protected]
上海源叶生物科技有限公司13636370518 · [email protected]
深圳菲斯生物科技有限公司0755-83725681-603
北京伊诺凯科技有限公司400-810-7969 010-59572699 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
上海倍卓生物科技有限公司021-61119791,13386096464 · [email protected]
上海湄水化工科技有限公司021-60549325 18616193163
上海将来实业股份有限公司400-0066400 13621662912 · [email protected]
上海将来实业股份有限公司021-61552785 · [email protected]
上海毕得医药科技股份有限公司400-164-7117 18317119277 · [email protected]
Labnetwork lnc.+86-27-50766799 +86-18062016861 · [email protected]
雷丁试剂0510-85629785 18013409632 · [email protected]
湖南华腾制药有限公司400-8592883 · [email protected]
上海麦克林生化科技股份有限公司15221275939 15221275939 · [email protected]
凯试(上海)科技有限公司021-50135380 · [email protected]
北京蓝博特科技有限公司010-56330744 18310155299 · [email protected]
Sigma-Aldrich西格玛奥德里奇(上海)贸易有限公司021-61415566 800-8193336 · [email protected]
珠海安哲生物科技有限公司13169972583 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
九鼎化学(上海)科技有限公司4009209199 · [email protected]
艾吉析科技(上海)有限公司17721401538;17717235263 17721401538 · [email protected]
sgtlifesciences pvt ltd+91-8790379245 · [email protected]
湖北扬信医药科技有限公司07143299675 13092790750 · [email protected]
上海西陇生化科技有限公司021-52907766-8042
成都华纯科技有限公司400-1166-196 15982826727 · [email protected]
广州市金华大化学试剂有限公司020-84383047 · [email protected]
上海尊理加生命科技有限公司021-34045219 13062664914 · [email protected]
陕西缔都医药化工有限公司029-81154043 17391733319 · [email protected]
Shanghai Acmec Biochemical Technology Co., Ltd.+86-18621343501 · [email protected]

Additional notes

DefinitionChEBI: The (S)-enantiomer of anabasine.

Related reactions

1 records
New reaction record
HRID 509260 reaction equation
HRID 509260As reactantuspto-grants-2015_08

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes